Cargando…

Epithelial-Mesenchymal Transition Phenotype Is Associated with Clinicopathological Factors That Indicate Aggressive Biological Behavior and Poor Clinical Outcomes in Invasive Breast Cancer

PURPOSE: Cancer tissue may display a wide spectrum of expression phenotypes of epithelial-mesenchymal transition (EMT)-related proteins. The purpose of this study was to investigate the clinical significance of EMT phenotypes in breast cancer. METHODS: We evaluated the expression pattern of the EMT-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Young Kyung, Choi, Jung Eun, Kang, Su Hwan, Lee, Soo Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600690/ https://www.ncbi.nlm.nih.gov/pubmed/26472976 http://dx.doi.org/10.4048/jbc.2015.18.3.256

Ejemplares similares

Matrix metalloproteinase 2 contributes to aggressive phenotype, epithelial-mesenchymal transition and poor outcome in nasopharyngeal carcinoma
por: Li, Siyi, et al.
Publicado: (2019)

Gastrointestinal Carcinoma with Plasmacytoid Morphology: Positivity for c-MET, Arylsulfatase, and Markers of Epithelial-Mesenchymal Transition, as Indicators of Aggressivity
por: Kovacs, Zsolt, et al.
Publicado: (2019)

Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma
por: Jayachandran, Aparna, et al.
Publicado: (2014)

Transformation of Mouse Liver Cells by Methylcholanthrene Leads to Phenotypic Changes Associated with Epithelial-mesenchymal Transition
por: Oh, Jiyun, et al.
Publicado: (2014)

Epithelial-mesenchymal transition in keloid tissue
por: Yang, Chae-Eun, et al.
Publicado: (2018)

Immunohistochemical Expressions of Senescence-Associated Secretory Phenotype and Its Association With Immune Microenvironments and Clinicopathological Factors in Invasive Breast Cancer
por: Park, Min Hui, et al.
Publicado: (2021)

NEDD9 Is a Positive Regulator of Epithelial-Mesenchymal Transition and Promotes Invasion in Aggressive Breast Cancer
por: Kong, Chenfei, et al.
Publicado: (2011)

Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer
por: Wu, Fengjie, et al.
Publicado: (2017)

Epithelial-mesenchymal Transition and Cell Invasion
por: Son, Hwajin, et al.
Publicado: (2010)

Acidic Growth Conditions Promote Epithelial-to-Mesenchymal Transition to Select More Aggressive PDAC Cell Phenotypes In Vitro
por: Audero, Madelaine Magalì, et al.
Publicado: (2023)

Translationally Controlled Tumor Protein induces epithelial to mesenchymal transition and promotes cell migration, invasion and metastasis
por: Bae, Seong-Yeon, et al.
Publicado: (2015)

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
por: Morandi, Andrea, et al.
Publicado: (2017)

Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition
por: He, Lu, et al.
Publicado: (2014)

HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition
por: Li, Pin-Dong, et al.
Publicado: (2018)

ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma
por: Zhang, Huan, et al.
Publicado: (2022)

The Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas
por: Jang, Se Min, et al.
Publicado: (2012)

The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients
por: Børretzen, Astrid, et al.
Publicado: (2021)

The mitotic checkpoint regulator RAE1 induces aggressive breast cancer cell phenotypes by mediating epithelial-mesenchymal transition
por: Oh, Ji Hoon, et al.
Publicado: (2017)

Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma
por: Hu, Yong, et al.
Publicado: (2016)

E2F8 regulates the proliferation and invasion through epithelial-mesenchymal transition in cervical cancer
por: Kim, Lee Kyung, et al.
Publicado: (2020)

Ursodeoxycholic acid inhibits epithelial-mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An in vitro study
por: Lee, Jin, et al.
Publicado: (2022)

Adenomyosis-derived extracellular vesicles endow endometrial epithelial cells with an invasive phenotype through epithelial-mesenchymal transition
por: Chen, Dayong, et al.
Publicado: (2020)

Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells
por: Huang, Cheng-Shuo, et al.
Publicado: (2020)

Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma
por: Yao, Xing, et al.
Publicado: (2012)

Transketolase Serves a Poor Prognosticator in Esophageal Cancer by Promoting Cell Invasion via Epithelial-Mesenchymal Transition
por: Chao, Yin-Kai, et al.
Publicado: (2016)

Overexpression of stromal interaction molecule 1 may promote epithelial-mesenchymal transition and indicate poor prognosis in gastric cancer
por: Wu, Guobin, et al.
Publicado: (2017)

Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
por: Ma, Wei, et al.
Publicado: (2022)

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
por: Kyung, Sun Young, et al.
Publicado: (2018)

SOX9 is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition
por: Francis, Jeffrey C., et al.
Publicado: (2018)

Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
por: Yang, Ying, et al.
Publicado: (2021)

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget
por: Zlobec, Inti, et al.
Publicado: (2010)

Epithelial-Mesenchymal Transition in Keratocystic Odontogenic Tumor: Possible Role in Locally Aggressive Behavior
por: Zhong, Wen-Qun, et al.
Publicado: (2015)

Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer
por: Fici, Pietro, et al.
Publicado: (2016)

E2F8 Induces Cell Proliferation and Invasion through the Epithelial–Mesenchymal Transition and Notch Signaling Pathways in Ovarian Cancer
por: Eoh, Kyung Jin, et al.
Publicado: (2020)

FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition
por: Cho, Sang Hee, et al.
Publicado: (2017)

Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells with MET Amplification
por: La Monica, Silvia, et al.
Publicado: (2013)

Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy
por: De Rosa, Viviana, et al.
Publicado: (2021)

MiR-23b-3p suppresses epithelial-mesenchymal transition, migration, and invasion of hepatocellular carcinoma cells by targeting c-MET
por: Park, Na Ri, et al.
Publicado: (2022)

Epithelial to mesenchymal transition in tumor cells as consequence of phenotypic instability
por: García de Herreros, Antonio
Publicado: (2014)

Ahnak promotes tumor metastasis through transforming growth factor-β-mediated epithelial-mesenchymal transition
por: Sohn, Mira, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g45cfsc81vqold18js0l2hfprl